Nisa Investment Advisors
BSX icon

Nisa Investment Advisors’s Boston Scientific BSX Stock Holding History

Nisa Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Sell
251,661
-121,170
-32% -$9.69M 0.06% 195
2025
Q4 		$35.5M Sell
372,831
-18,182
-5% -$1.78M 0.12% 98
2025
Q3 		$38.2M Buy
391,013
+7,200
+2% +$746K 0.15% 93
2025
Q2 		$41.2M Sell
383,813
-22,142
-5% -$2.24M 0.19% 83
2025
Q1 		$41M Buy
405,955
+17,160
+4% +$1.73M 0.2% 82
2024
Q4 		$34.7M Buy
388,795
+10,969
+3% +$966K 0.13% 118
2024
Q3 		$31.7M Buy
377,826
+4,959
+1% +$391K 0.19% 111
2024
Q2 		$28.7M Buy
372,867
+50,397
+16% +$3.69M 0.18% 111
2024
Q1 		$22.1M Sell
322,470
-7,025
-2% -$452K 0.14% 156
2023
Q4 		$19M Buy
329,495
+531
+0.2% +$28.3K 0.14% 164
2023
Q3 		$17.4M Sell
328,964
-4,800
-1% -$252K 0.13% 178
2023
Q2 		$18.1M Sell
333,764
-718
-0.2% -$37.5K 0.13% 169
2023
Q1 		$16.7M Buy
334,482
+12,416
+4% +$585K 0.13% 175
2022
Q4 		$14.9M Sell
322,066
-9,160
-3% -$397K 0.12% 201
2022
Q3 		$12.9M Buy
331,226
+41,572
+14% +$1.67M 0.11% 201
2022
Q2 		$10.8M Sell
289,654
-12,360
-4% -$503K 0.09% 228
2022
Q1 		$13.4M Sell
302,014
-9,120
-3% -$395K 0.09% 216
2021
Q4 		$13.3M Buy
311,134
+14,256
+5% +$599K 0.1% 212
2021
Q3 		$12.9K Sell
296,878
-6,270
-2% -$277K 0.08% 230
2021
Q2 		$13K Sell
303,148
-18,315
-6% -$771K 0.08% 223
2021
Q1 		$12.4K Sell
321,463
-141,287
-31% -$5.35M 0.08% 240
2020
Q4 		$16.6M Buy
462,750
+34,519
+8% +$1.24M 0.11% 198
2020
Q3 		$16.4M Sell
428,231
-22,447
-5% -$865K 0.13% 170
2020
Q2 		$15.8M Buy
450,678
+67,072
+17% +$2.42M 0.15% 150
2020
Q1 		$12.5M Sell
383,606
-49,420
-11% -$1.93M 0.14% 158
2019
Q4 		$19.6M Buy
433,026
+22,991
+6% +$962K 0.17% 132
2019
Q3 		$16.7M Sell
410,035
-8,776
-2% -$372K 0.15% 153
2019
Q2 		$18M Buy
418,811
+14,800
+4% +$569K 0.17% 132
2019
Q1 		$15.5M Buy
404,011
+6,410
+2% +$245K 0.15% 148
2018
Q4 		$14.1M Buy
397,601
+9,750
+3% +$354K 0.16% 142
2018
Q3 		$14.9M Buy
387,851
+67,911
+21% +$2.37M 0.14% 165
2018
Q2 		$10.5M Buy
319,940
+124,350
+64% +$3.75M 0.11% 199
2018
Q1 		$5.34M Buy
195,590
+3,200
+2% +$87K 0.06% 320
2017
Q4 		$4.77M Sell
192,390
-28,800
-13% -$794K 0.05% 352
2017
Q3 		$6.45M Buy
221,190
+25,750
+13% +$711K 0.07% 273
2017
Q2 		$5.37M Buy
195,440
+10,150
+5% +$269K 0.06% 315
2017
Q1 		$4.61M Sell
185,290
-2,795
-1% -$68K 0.05% 350
2016
Q4 		$4.07M Sell
188,085
-10,550
-5% -$230K 0.05% 365
2016
Q3 		$4.73M Sell
198,635
-500
-0.3% -$11.9K 0.06% 329
2016
Q2 		$4.65M Buy
199,135
+25,875
+15% +$560K 0.06% 328
2016
Q1 		$3.26M Buy
173,260
+106,000
+158% +$1.86M 0.05% 392
2015
Q4 		$1.24M Hold
67,260
– – 0.02% 679
2015
Q3 		$1.1M Buy
67,260
+5,000
+8% +$85.5K 0.02% 699
2015
Q2 		$1.1M Sell
62,260
-500
-0.8% -$8.94K 0.02% 739
2015
Q1 		$1.11M Buy
62,760
+24,500
+64% +$387K 0.02% 753
2014
Q4 		$507K Buy
38,260
+7,900
+26% +$101K 0.01% 1007
2014
Q3 		$359K Sell
30,360
-22,000
-42% -$277K 0.01% 1099
2014
Q2 		$669K Buy
52,360
+12,000
+30% +$156K 0.01% 947
2014
Q1 		$546K Hold
40,360
– – 0.01% 1002
2013
Q4 		$485K Buy
40,360
+3,900
+11% +$46.1K 0.01% 1035
2013
Q3 		$428K Buy
36,460
+1,300
+4% +$14.1K 0.01% 1063
2013
Q2 		$326K Buy
+35,160
New +$298K 0.01% 1133

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nisa Investment Advisors's BSX Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Boston Scientific (BSX) stake by 32% in Q1 2026, selling an estimated $9.69M and leaving 251,661 shares worth $15.8M. The position accounts for 0.06% of the portfolio, ranked #195.

Nisa Investment Advisors first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $41.2M in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Nisa Investment Advisors held 251,661 shares of Boston Scientific worth $15.8M as of Q1 2026.
  • Nisa Investment Advisors sold 121,170 Boston Scientific shares in Q1 2026, an estimated $9.69M.
  • Boston Scientific made up 0.06% of Nisa Investment Advisors's portfolio in Q1 2026, its #195 holding.
  • Nisa Investment Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Boston Scientific position peaked at $41.2M in Q2 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.